Pivotal bioVenture Partners

Pivotal bioVenture Partners is a venture capital firm based in San Francisco, established in 2017, with a focus on the life sciences sector. The firm manages a $300 million fund and targets early-stage investments in privately held companies in North America and Europe that are dedicated to developing innovative therapeutic products and platforms to meet significant unmet medical needs. Pivotal bioVenture Partners invests throughout a company's lifecycle, from inception to mid and late-stage clinical development. The firm's team possesses a diverse range of expertise in venture capital, company building, and drug discovery, enabling them to effectively collaborate with entrepreneurs and support the advancement of their businesses.